VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2 | +100.0% | 13,500 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -83.3% | 13,500 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -29.4% | 13,500 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -34.6% | 13,500 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -39.5% | 13,500 | 0.0% | 0.00% | – |
| Q2 2021 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q1 2021 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q1 2020 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2019 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | 0.0% | 13,500 | 0.0% | 0.00% | – |
| Q1 2019 | $43,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $14,553,000 | 6.80% |
| VR Adviser, LLC | 16,047,286 | $19,899,000 | 3.22% |
| COMMODORE CAPITAL LP | 10,097,229 | $12,521,000 | 2.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,951,423 | $6,140,000 | 0.87% |
| EPIQ PARTNERS, LLC | 1,161,350 | $1,440,000 | 0.77% |
| NEA Management Company, LLC | 16,302,596 | $20,215,000 | 0.58% |
| Nicholas Investment Partners, LP | 4,570,387 | $5,667,000 | 0.40% |
| Ghost Tree Capital, LLC | 1,315,154 | $1,631,000 | 0.35% |
| Orbimed Advisors | 12,909,283 | $16,008,000 | 0.26% |
| HighVista Strategies LLC | 315,880 | $392,000 | 0.25% |